Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
REGENERON PHARMACEUTICALS, INC. | Bd. Co-Chair, President & CEO, Director | Common Stock | 466,877 | $479 M | $1,025.27 | Jun 11, 2024 | Direct |
REGENERON PHARMACEUTICALS, INC. | Bd. Co-Chair, President & CEO, Director | Common Stock | 157,552 | $162 M | $1,025.27 | Jun 11, 2024 | 2023 GRAT |
REGENERON PHARMACEUTICALS, INC. | Bd. Co-Chair, President & CEO, Director | Common Stock | 39,985 | $40.6 M | $1,016.62 | Jun 12, 2024 | By Trust |
REGENERON PHARMACEUTICALS, INC. | Bd. Co-Chair, President & CEO, Director | Common Stock | 5,932 | $6.08 M | $1,025.27 | Jun 11, 2024 | By 401(k) Plan |
REGENERON PHARMACEUTICALS, INC. | Bd. Co-Chair, President & CEO, Director | Common Stock | 0 | $0 | $1,025.27 | Jun 12, 2024 | by Trust for Son |
REGENERON PHARMACEUTICALS, INC. | Bd. Co-Chair, President & CEO, Director | Class A Stock | 1,710,790 | Jun 11, 2024 | Direct | ||
REGENERON PHARMACEUTICALS, INC. | Bd. Co-Chair, President & CEO, Director | Class A Stock | 14,775 | Jun 12, 2024 | by Trust for Son | ||
REGENERON PHARMACEUTICALS, INC. | Bd. Co-Chair, President & CEO, Director | 2019 Performance Stock Units | 0 | $844.09 | Dec 11, 2023 | Direct | |
REGENERON PHARMACEUTICALS, INC. | Bd. Co-Chair, President & CEO, Director | Non-Qualified Stock Option (right to buy) | 0 | May 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
REGN | REGENERON PHARMACEUTICALS, INC. | Jun 11, 2024 | 7 | -25,610,229 | 4 | Jun 13, 2024 | Bd. Co-Chair, President & CEO, Director |
REGN | REGENERON PHARMACEUTICALS, INC. | Jun 6, 2024 | 1 | -798,821 | 4 | Jun 10, 2024 | Bd. Co-Chair, President & CEO, Director |
REGN | REGENERON PHARMACEUTICALS, INC. | May 17, 2024 | 2 | -22,355,714 | 4 | May 17, 2024 | Bd. Co-Chair, President & CEO, Director |
REGN | REGENERON PHARMACEUTICALS, INC. | May 13, 2024 | 15 | -95,075,310 | 4 | May 15, 2024 | Bd. Co-Chair, President & CEO, Director |
REGN | REGENERON PHARMACEUTICALS, INC. | Dec 11, 2023 | 3 | -10,838,960 | 4 | Dec 13, 2023 | Bd. Co-Chair, President & CEO, Director |
REGN | REGENERON PHARMACEUTICALS, INC. | May 15, 2023 | 2 | 0 | 4 | May 17, 2023 | President & CEO, Director |
REGN | REGENERON PHARMACEUTICALS, INC. | Apr 5, 2022 | 2 | -5,051,269 | 4 | Apr 7, 2022 | President & CEO, Director |
REGN | REGENERON PHARMACEUTICALS, INC. | Mar 31, 2022 | 1 | -2,049,089 | 4 | Apr 4, 2022 | President & CEO, Director |
REGN | REGENERON PHARMACEUTICALS, INC. | Nov 19, 2021 | 6 | -119,112,839 | 4 | Nov 19, 2021 | President & CEO, Director |
REGN | REGENERON PHARMACEUTICALS, INC. | Aug 18, 2021 | 2 | -136,606,300 | 4 | Aug 20, 2021 | President & CEO, Director |
REGN | REGENERON PHARMACEUTICALS, INC. | Aug 16, 2021 | 15 | -6,243,614 | 4 | Aug 17, 2021 | President & CEO, Director |
REGN | REGENERON PHARMACEUTICALS, INC. | Aug 6, 2021 | 8 | -118,049,598 | 4 | Aug 10, 2021 | President & CEO, Director |